The Clinical Efficacy and Multimodal Imaging Mechanism of the Knot-tying Technique in the Treatment of Chronic Neck Pain
Clinical Efficacy and Multimodal Imaging Mechanisms of Jiejie Acupuncture for Chronic Neck Pain
1 other identifier
interventional
60
0 countries
N/A
Brief Summary
This study is a multicenter 1:1 randomized controlled trial, enrolling patients with chronic neck pain from the Rehabilitation Medicine Department of Huizhou Third People's Hospital. A total of 60 participants are planned to be recruited, divided 1:1 into a trial group receiving the knot-release acupuncture method and a sham acupuncture control group. The study aims to evaluate the immediate clinical efficacy and safety of the knot-release acupuncture method for treating chronic neck pain and to explore its peripheral-to-central mechanisms using multimodal detection technologies. The research content includes:
- 1.Dynamically monitoring core evaluation indicators in enrolled patients, including VAS scores, real-time shear wave elastography (SWE), cervical range of motion (ROM), Neck Disability Index (NDI-TH), and functional near-infrared spectroscopy (fNIRS), to assess the immediate clinical efficacy and safety of the knot-release acupuncture method for chronic neck pain.
- 2.Observing and recording any adverse events throughout the intervention period, systematically and scientifically evaluating the clinical safety of the knot-release acupuncture method for chronic neck pain, and providing a safety basis for its standardized clinical application.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jan 2027
Typical duration for not_applicable
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
First Submitted
Initial submission to the registry
October 12, 2026
CompletedFirst Posted
Study publicly available on registry
October 23, 2026
CompletedStudy Start
First participant enrolled
January 1, 2027
ExpectedPrimary Completion
Last participant's last visit for primary outcome
December 31, 2028
Study Completion
Last participant's last visit for all outcomes
December 31, 2028
October 23, 2026
October 1, 2026
2 years
October 12, 2026
October 18, 2026
Conditions
Outcome Measures
Primary Outcomes (2)
Visual Analogue Scale(VAS)
* Score range: 0-10 points * 0 points: no pain * 10 points: the most severe pain imaginable * Meaning of the score: the higher the score, the more intense the pain (worse)
Baseline, immediately after treatment
Trapezius shear modulus measured by a soft tissue mechanical imager using real-time shear wave elastography (SWE) technology and 2D ultrasound qualitative imaging features
Using a soft tissue mechanical imaging device, we employ real-time shear wave elastography (SWE) to detect active myofascial trigger points (MTrPs) in the upper trapezius. Participants sit or lie face down, with their head and elbows fixed in position. The upper trapezius MTrPs are located using standardized palpation methods. The probe is coated with 4 mm of coupling gel and gently placed on the skin, avoiding the fascia layer in the measurement scale, with a 5 mm gap between the excitation handle and the probe marker. For each measurement point, 10 sets of data are collected, and values with a relative error of less than 10% are considered valid. The median of these valid values is taken as the shear modulus result. During the measurement process, 2D ultrasound images of the target area are also collected, and the assessor qualitatively records the 2D ultrasound features such as echoes and morphology. Higher shear modulus values indicate the upper trapezius tissue is stiffer.
Baseline, immediately after treatment
Secondary Outcomes (3)
Cervical range of motion (ROM)
Baseline, immediately after treatment
Neck Disability Index (NDI-TH)
Baseline, immediately after treatment
Changes in oxygenated hemoglobin (HbO₂) concentration in the prefrontal and motor-related brain areas measured by multi-channel functional near-infrared spectroscopy (fNIRS)
Baseline, immediately after treatment
Study Arms (2)
Experimental group: JieJie Needle Therapy: needling with JieJie needles
EXPERIMENTALUnknotting Needling Treatment: Acupuncture with an unknotting needle Treatment Frequency: Use the acupuncture needle on the trigger point to provoke and release the knot, once a day, 3-5 minutes each time, for a total of 1 session
Control group: sham acupuncture
SHAM COMPARATORSham acupuncture, using needles of the same specification for shallow insertion at trigger points. Treatment frequency: shallow insertion depth of 3mm, once a day, 3-5 minutes each time, for a total of 1 treatment.
Interventions
Use acupuncture needles on the trigger points to provoke and relax them, once a day, 3-5 minutes each time, for a total of one treatment.
Sham acupuncture, using needles of the same specifications for shallow insertion at trigger points. Treatment frequency: shallow insertion depth of 3mm, once a day, 3-5 minutes each time, for a total of 1 treatment.
Eligibility Criteria
You may qualify if:
- Meet the diagnostic criteria for chronic neck pain;
- Aged 20-65, any gender;
- Experienced neck pain in the past 7 days and complain of neck pain and limited range of motion; ④ Diagnosed with chronic neck pain at their medical institution or another healthcare facility; ⑤ Have at least one active myofascial trigger point (MTrP) in the unilateral trapezius area; ⑥ Voluntarily choose to participate in this study and sign the informed consent form; ⑦ Visual analog scale (VAS) score ≥3 at rest;
You may not qualify if:
- Took medication or received treatment for neck or shoulder muscle pain or discomfort in the past 7 days;
- Have a history of neck surgery in the past 3 months;
- Suffered a neck sprain from trauma such as a traffic accident or contusion in the past 3 months;
- Have cervical radiculopathy, cervical disc herniation, spinal canal stenosis, fracture, dislocation, infection, tuberculosis, tumor, rheumatic autoimmune disease, spinal cord lesions, or severe neurological deficits;
- Have acute soft tissue injury, related rheumatic diseases, congenital cervical deformities, psychogenic pain, or suspected/confirmed vertebral or spinal canal tumors, tuberculosis, or severe osteoporosis; ⑥ Have severe heart (or has a pacemaker), liver, kidney, cerebrovascular, tumor diseases, or other conditions the researchers consider unsuitable for participation;
- ⑦ (Females only) Have been pregnant or given birth in the past 6 months;
- ⑧ Participated in other clinical intervention studies in the past 3 months;
- ⑨ Other individuals deemed unsuitable for the study by medical staff, such as those with impaired cognitive function who cannot understand the consent form or provide voluntary consent.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Li Juntaolead
Central Study Contacts
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- QUADRUPLE
- Who Masked
- PARTICIPANT, CARE PROVIDER, INVESTIGATOR, OUTCOMES ASSESSOR
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Chief Physician, Director of the Neurological Rehabilitation Ward at the Rehabilitation Medicine Center
Study Record Dates
First Submitted
October 12, 2026
First Posted
October 23, 2026
Study Start (Estimated)
January 1, 2027
Primary Completion (Estimated)
December 31, 2028
Study Completion (Estimated)
December 31, 2028
Last Updated
October 23, 2026
Record last verified: 2026-10
Data Sharing
- IPD Sharing
- Will not share